BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 18720457)

  • 1. Refinement of breast cancer classification by molecular characterization of histological special types.
    Weigelt B; Horlings HM; Kreike B; Hayes MM; Hauptmann M; Wessels LF; de Jong D; Van de Vijver MJ; Van't Veer LJ; Peterse JL
    J Pathol; 2008 Oct; 216(2):141-50. PubMed ID: 18720457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: the relationship between the outcome and the clinicopathological characteristics.
    Nagao T; Kinoshita T; Hojo T; Tsuda H; Tamura K; Fujiwara Y
    Breast; 2012 Jun; 21(3):289-95. PubMed ID: 22277312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type.
    Lacroix-Triki M; Suarez PH; MacKay A; Lambros MB; Natrajan R; Savage K; Geyer FC; Weigelt B; Ashworth A; Reis-Filho JS
    J Pathol; 2010 Nov; 222(3):282-98. PubMed ID: 20815046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucinous and neuroendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special type.
    Weigelt B; Geyer FC; Horlings HM; Kreike B; Halfwerk H; Reis-Filho JS
    Mod Pathol; 2009 Nov; 22(11):1401-14. PubMed ID: 19633645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomic analysis of tubular carcinomas of the breast reveals similarities and differences with molecular subtype-matched ductal and lobular carcinomas.
    Lopez-Garcia MA; Geyer FC; Natrajan R; Kreike B; Mackay A; Grigoriadis A; Reis-Filho JS; Weigelt B
    J Pathol; 2010 Sep; 222(1):64-75. PubMed ID: 20593406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic profiling of histological special types of breast cancer.
    Horlings HM; Weigelt B; Anderson EM; Lambros MB; Mackay A; Natrajan R; Ng CK; Geyer FC; van de Vijver MJ; Reis-Filho JS
    Breast Cancer Res Treat; 2013 Nov; 142(2):257-69. PubMed ID: 24162157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type.
    Weigelt B; Geyer FC; Natrajan R; Lopez-Garcia MA; Ahmad AS; Savage K; Kreike B; Reis-Filho JS
    J Pathol; 2010 Jan; 220(1):45-57. PubMed ID: 19877120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of calretinin in high-grade hormone receptor-negative invasive breast carcinomas: correlation with histological and molecular subtypes.
    Micello D; Bossi A; Marando A; Dainese E; Sessa F; Capella C
    Virchows Arch; 2017 Jul; 471(1):13-21. PubMed ID: 28550498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis.
    Turashvili G; Bouchal J; Baumforth K; Wei W; Dziechciarkova M; Ehrmann J; Klein J; Fridman E; Skarda J; Srovnal J; Hajduch M; Murray P; Kolar Z
    BMC Cancer; 2007 Mar; 7():55. PubMed ID: 17389037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
    Adachi Y; Ishiguro J; Kotani H; Hisada T; Ichikawa M; Gondo N; Yoshimura A; Kondo N; Hattori M; Sawaki M; Fujita T; Kikumori T; Yatabe Y; Kodera Y; Iwata H
    BMC Cancer; 2016 Mar; 16():248. PubMed ID: 27015895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare breast cancer subtypes: histological, molecular, and clinical peculiarities.
    Dieci MV; Orvieto E; Dominici M; Conte P; Guarneri V
    Oncologist; 2014 Aug; 19(8):805-13. PubMed ID: 24969162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas.
    Simpson PT; Reis-Filho JS; Lambros MB; Jones C; Steele D; Mackay A; Iravani M; Fenwick K; Dexter T; Jones A; Reid L; Da Silva L; Shin SJ; Hardisson D; Ashworth A; Schmitt FC; Palacios J; Lakhani SR
    J Pathol; 2008 Jul; 215(3):231-44. PubMed ID: 18473330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
    Zhao H
    Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reappraisal of immunohistochemical profiling of special histological types of breast carcinomas: a study of 121 cases of eight different subtypes.
    Alvarenga CA; Paravidino PI; Alvarenga M; Gomes M; Dufloth R; Zeferino LC; Vassallo J; Schmitt FC
    J Clin Pathol; 2012 Dec; 65(12):1066-71. PubMed ID: 22944625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different gene expression patterns in invasive lobular and ductal carcinomas of the breast.
    Zhao H; Langerød A; Ji Y; Nowels KW; Nesland JM; Tibshirani R; Bukholm IK; Kåresen R; Botstein D; Børresen-Dale AL; Jeffrey SS
    Mol Biol Cell; 2004 Jun; 15(6):2523-36. PubMed ID: 15034139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population.
    Wang T; Ma Y; Wang L; Liu H; Chen M; Niu R
    Tumour Biol; 2015 Aug; 36(8):6113-24. PubMed ID: 25804795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological types of breast cancer: how special are they?
    Weigelt B; Geyer FC; Reis-Filho JS
    Mol Oncol; 2010 Jun; 4(3):192-208. PubMed ID: 20452298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer pathology: the impact of molecular taxonomy on morphological taxonomy.
    Masuda S
    Pathol Int; 2012 May; 62(5):295-302. PubMed ID: 22524656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenomic and Transcriptomic Characterization of Secondary Breast Cancers.
    Graff-Baker AN; Orozco JIJ; Marzese DM; Salomon MP; Hoon DSB; Goldfarb M
    Ann Surg Oncol; 2018 Oct; 25(10):3082-3087. PubMed ID: 29956094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers.
    Wetterskog D; Lopez-Garcia MA; Lambros MB; A'Hern R; Geyer FC; Milanezi F; Cabral MC; Natrajan R; Gauthier A; Shiu KK; Orr N; Shousha S; Gatalica Z; Mackay A; Palacios J; Reis-Filho JS; Weigelt B
    J Pathol; 2012 Jan; 226(1):84-96. PubMed ID: 22015727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.